Cargando…
Correction to: N-Myc promotes therapeutic resistance development of neuroendocrine prostate cancer by differentially regulating miR-421/ ATM pathway
Autores principales: | Yin, Yu, Xu, Lingfan, Chang, Yan, Zeng, Tao, Chen, Xufeng, Wang, Aifen, Groth, Jeff, Foo, Wen-Chi, Liang, Chaozhao, Hu, Hailiang, Huang, Jiaoti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6582568/ https://www.ncbi.nlm.nih.gov/pubmed/31217018 http://dx.doi.org/10.1186/s12943-019-1034-y |
Ejemplares similares
-
N-Myc promotes therapeutic resistance development of neuroendocrine prostate cancer by differentially regulating miR-421/ATM pathway
por: Yin, Yu, et al.
Publicado: (2019) -
Targeting androgen receptor-independent pathways in therapy-resistant prostate cancer
por: Xu, Lingfan, et al.
Publicado: (2019) -
Therapeutic potential of ReACp53 targeting mutant p53 protein in CRPC
por: Zhang, Yaqun, et al.
Publicado: (2019) -
Serum lipid profiles and aggressive prostate cancer
por: Li, Yanjing, et al.
Publicado: (2015) -
miR-421 and miR-30c Inhibit SERPINE 1 Gene Expression in Human Endothelial Cells
por: Marchand, Alexandre, et al.
Publicado: (2012)